EDN1 and obesity disorder: Although ET-1 can impair adipogenesis by inhibiting the differentiation of preadipocytes into adipocytes and reducing lipid accumulation, potentially contributing to dysfunctional adipose tissue remodeling in obesity, ET-1 infusion can induce fat cell hyperplasia 29, 36, 37.